La Jolla to acquire Tetraphase Pharma

La Jolla to acquire Tetraphase Pharma

Source: 
Seeking Alpha
snippet: 

La Jolla Pharmaceutical (NASDAQ:LJPC) and Tetraphase Pharmaceuticals (NASDAQ:TTPH) have entered into a definitive merger agreement, under which La Jolla would acquire Tetraphase, through a tender offer, for $43M in upfront cash plus potential future cash payments of up to $16M pursuant to contingent value rights (CVRs).